KR900700600A - DNA를 코오딩하는 IgE수용체 α-서브유니트 또는 그의 단편 - Google Patents

DNA를 코오딩하는 IgE수용체 α-서브유니트 또는 그의 단편

Info

Publication number
KR900700600A
KR900700600A KR1019890701432A KR890701432A KR900700600A KR 900700600 A KR900700600 A KR 900700600A KR 1019890701432 A KR1019890701432 A KR 1019890701432A KR 890701432 A KR890701432 A KR 890701432A KR 900700600 A KR900700600 A KR 900700600A
Authority
KR
South Korea
Prior art keywords
subunit
ige
fragment
surface receptor
ige receptor
Prior art date
Application number
KR1019890701432A
Other languages
English (en)
Other versions
KR970009936B1 (ko
Inventor
시라가니안 뤼벤
레더 필립
벤페이 필립
아키라 시미즈
Original Assignee
시라가니안 뤼벤
원본미기재
프레지던트 앤드 펠로우즈 오브 하바드 칼리지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22428905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR900700600(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 시라가니안 뤼벤, 원본미기재, 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 filed Critical 시라가니안 뤼벤
Publication of KR900700600A publication Critical patent/KR900700600A/ko
Application granted granted Critical
Publication of KR970009936B1 publication Critical patent/KR970009936B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

내용 없음

Description

DNA를 코오딩하는 IgE수용체 α-서브유니트 또는 그의 단편
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 쥐 IgE 표면 수용체 α-서브유니트 트립틱(tryptic) 분해 단편들의 HPLC 용출 프로필이고
제2도는 2개의 쥐 IgE α-서브유니트 클론에 대한 제한지도 한쌍이며
제3도는 인체 IgE 수용체 α-서브유니트 클론에 대한 제한지도이고; 및
제4도는 쥐와 사람의 IgE 수용체 α-서브유니트 클론들의 DNA 서열을 도식적으로 비교한 것이다.

Claims (4)

  1. 인체 유선세포 IgE 표면 수용체의 α-서브유니트 또는 그의 IgE 결합 단편을 코오딩하는 cDNA 서열.
  2. 인체 유선세포 IgE 표면 수용체의 α-서브유니트 또는 그의 IgE 결합 단편을 코오딩하는 DNA를 함유하는 벡타.
  3. 인체 IgE와 결합할 수 있는, 인체 유선세포 IgE 표면 수용체의 α-서브유니트 가용성 단편.
  4. 인체 유선세포 IgE 표면 수용체의 재조합 α-서브유니트.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890701432A 1987-12-01 1988-11-29 lgE 수용체 α-서브유니트 또는 그의 단편, 이들을 암호화하는 DNA 및 이 DNA를 포함하는 벡터 KR970009936B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/127,214 US4962035A (en) 1987-12-01 1987-12-01 DNA encoding IgE receptor alpha-subunit or fragment thereof
US127.214 1987-12-01
US127,214 1987-12-01
PCT/US1988/004255 WO1989005352A1 (en) 1987-12-01 1988-11-29 DNA ENCODING IgE RECEPTOR alpha-SUBUNIT OR FRAGMENT THEREOF

Publications (2)

Publication Number Publication Date
KR900700600A true KR900700600A (ko) 1990-08-16
KR970009936B1 KR970009936B1 (ko) 1997-06-19

Family

ID=22428905

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890701432A KR970009936B1 (ko) 1987-12-01 1988-11-29 lgE 수용체 α-서브유니트 또는 그의 단편, 이들을 암호화하는 DNA 및 이 DNA를 포함하는 벡터

Country Status (11)

Country Link
US (2) US4962035A (ko)
EP (1) EP0394302B1 (ko)
JP (1) JP3117206B2 (ko)
KR (1) KR970009936B1 (ko)
AT (1) ATE177148T1 (ko)
AU (1) AU625434B2 (ko)
CA (1) CA1341538C (ko)
DE (1) DE3856309T2 (ko)
DK (2) DK175974B1 (ko)
NO (1) NO310424B1 (ko)
WO (1) WO1989005352A1 (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451669A (en) * 1986-05-29 1995-09-19 The University Of Melbourne DNA encoding for an Fc receptor for immunoglobulin
US5985599A (en) * 1986-05-29 1999-11-16 The Austin Research Institute FC receptor for immunoglobulin
US5639660A (en) 1988-02-24 1997-06-17 Hoffmann-La Roche Inc. Polypeptide and DNA sequence corresponding to the human receptor with high affinity for IgE
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies
US5516651A (en) * 1991-11-15 1996-05-14 The General Hospital Corporation Nucleic acids encoding calcitonin receptor and uses thereof
US5770396A (en) 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
KR950702628A (ko) * 1992-08-01 1995-07-29 치세이 라 항알레르기 조성물(Antiallergic agent)
US5874404A (en) * 1992-08-04 1999-02-23 Chisei Ra Immunoglobulin E receptor α-chain inhibits IgE production and secondary allergic responses
ATE157455T1 (de) * 1993-12-10 1997-09-15 Genentech Inc Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika
EP0739214B1 (en) * 1994-01-18 1998-03-18 Genentech, Inc. A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
US6685940B2 (en) 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
US20040197326A1 (en) * 1995-07-27 2004-10-07 Genentech, Inc. Method for treatment of allergic asthma
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
GB9526599D0 (en) 1995-12-28 1996-02-28 Sandoz Ltd Elisa test system
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
PE99498A1 (es) * 1996-07-26 1999-01-21 Novartis Ag Polipeptidos de fusion
US6391569B1 (en) * 1996-09-18 2002-05-21 Heska Corporation Method to detect Dirofilaria immitis infection
AU769954B2 (en) * 1996-11-26 2004-02-12 Heska Corporation Method to detect IgE
US5945294A (en) 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US5958880A (en) 1996-12-19 1999-09-28 Heska Corporation Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
US6060326A (en) * 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
US6057127A (en) 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
WO2000026246A2 (en) * 1998-11-05 2000-05-11 Heska Corporation Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
US6889145B1 (en) * 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
CA2403739A1 (en) * 2000-03-15 2001-09-20 Heska Corporation Three-dimensional model of a complex between a fc epsilon receptor alpha chain and a fc region of an ige antibody and uses thereof
US20030022250A1 (en) * 2001-05-29 2003-01-30 Dreskin Stephen C. Functional IgE test methods and compositions
WO2004041862A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
EP2267032A3 (en) 2002-11-08 2011-11-09 Ablynx N.V. Method of administering therapeutic polypeptides, and polypeptides therefor
EP3192806A1 (en) 2016-01-13 2017-07-19 Affiris AG Alpha chain of the high-affinity ige receptor (fceria)
CN110716054A (zh) * 2019-09-11 2020-01-21 天津医科大学 一种血清亲细胞性免疫球蛋白e的定量检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6385886A (en) * 1986-10-10 1988-04-14 Medical Biology Institute Production of ige-binding protein by recombinant methods

Also Published As

Publication number Publication date
JP3117206B2 (ja) 2000-12-11
KR970009936B1 (ko) 1997-06-19
US4962035A (en) 1990-10-09
CA1341538C (en) 2007-08-28
NO902393D0 (no) 1990-05-30
EP0394302A1 (en) 1990-10-31
NO310424B1 (no) 2001-07-02
WO1989005352A1 (en) 1989-06-15
NO902393L (no) 1990-05-30
DK176181B1 (da) 2006-12-11
US7202333B1 (en) 2007-04-10
AU625434B2 (en) 1992-07-09
ATE177148T1 (de) 1999-03-15
DK175974B1 (da) 2005-10-10
DE3856309D1 (de) 1999-04-08
EP0394302A4 (en) 1991-09-11
DK134790D0 (da) 1990-05-31
AU2610588A (en) 1989-07-05
DE3856309T2 (de) 1999-07-15
DK134790A (da) 1990-07-25
EP0394302B1 (en) 1999-03-03
JPH03502878A (ja) 1991-07-04
DK200500682A (da) 2005-05-11

Similar Documents

Publication Publication Date Title
KR900700600A (ko) DNA를 코오딩하는 IgE수용체 α-서브유니트 또는 그의 단편
PT804482E (pt) Citoquinas que se ligam ao receptor hek da superficie celular
DE3781335D1 (de) Immunoassay mit verwendung von kolloidalem gold.
DE68912464D1 (de) Rückverflüssigung von verdampftem Flüssigerdgas.
DE69033710D1 (de) Sekretion vom mit Gamma-Interferon Signalpeptid gebundenen humänen Protein
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
DE3789273T2 (de) Kodierungssystem zur Reduktion der Redundanz.
DE69533923D1 (de) Cytokinin-designiertes lerk-5
DE3884529T2 (de) Leader-anteile zur produktion von rekombinanten proteinen.
DK517986A (da) Dna-sekvenser, rekombinant-dna-molekyler og fremgangsmaade til fremstilling af mueller-inhiberende stof-lignende polypeptider
NO864759D0 (no) Eutaryotiske fusjonsproteiner, fremstilling og anvendelse derav samt middel til gjennomfoering av fremgangsmaaten.
ES8706827A1 (es) Procedimiento para preparar polipeptidos.
IT8419142A0 (it) Analoghi retro-invertiti esapeptidici c-terminali della sostanza p.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
NO873216D0 (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
KR910003095A (ko) 사람의 단백질 c변이체 및 이의 제조방법
FI971276A (fi) Lerk-6:ksi nimetty sytokiini
NO874738L (no) Skipsskrog for smaa fartoeyer og hoeye hastigheter.
DE3780591D1 (de) Kryogendetektorschnittstelle mit dielektrischen silikongel.
PT728015E (pt) Antigenes polipeptidicos combinatoriais
IT8620548A0 (it) Procedimento e dispositivo per la fabbricazione di prodotti in fibra di vetro, per esempio veli, feltri, filati e stoppini.
DE3771607D1 (de) Kryogene rueckgewinnung von hochreinem wasserstoff.
NO881502D0 (no) Rekombinante htlv-111 proteiner og anvendelse av disse.
NO873512L (no) Human lav-affinitets fcepsilon-reseptor, isolering, rekombinant fremstilling og rensing av denne.
DE69400945D1 (de) Herstellung von Siliziumnitrid-Pulver mit hohem Alpha-Gehalt

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20111010

Year of fee payment: 15

EXPY Expiration of term